Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 115
interventional 99
Observational 11
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 36
Drug|Other 16
Biological 8
Biological|Drug 5
Drug|Radiation 5
Device 4
Drug|Procedure 4
Procedure 4
Drug|Other|Procedure 3
Drug|placebo 2
Other 2
Behavioral|Other 1
Biological|Drug|Other 1
Biological|Other 1
Combination Product 1
Device|Procedure 1
Drug|Genetic|Other 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Other|Procedure|Radiation 1
Drug|Procedure|Radiation 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 57
China 9
United Kingdom 7
Korea, Republic of 6
India 4
France 2
Germany 2
Sweden 2
Australia|Austria|Denmark|Germany|Netherlands|United Kingdom 1
Chile 1
Denmark 1
Italy 1
NA 1
Spain 1
Switzerland 1
United States|Argentina|Australia|Chile|Japan|Korea, Republic of|Poland|Spain|Taiwan 1
United States|Canada 1
United States|China|France|Italy|Japan|Korea, Republic of|Spain|Taiwan|United Kingdom 1

Sites per Study

Site_count Study_Count
1 55
2 10
3 9
4 1
5 4
8 2
11 1
15 1
17 1
19 1
20 1
21 1
25 1
32 1
37 1
41 1
46 1
64 1
68 1
112 1
141 1
251 1
295 1
620 1

Phase

Phase Study_Count
Phase 2 46
Phase 1 24
Phase 3 10
N/A 8
Phase 1/Phase 2 6
Phase 2/Phase 3 4
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 51
2 33
3 4
5 1
NA 10

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20.00 7.00000 19.00000 4.00000 34.0 92.0 400
1st Qu. 40.50 16.50000 30.00000 30.75000 53.5 196.5 400
Median 59.00 29.00000 64.00000 49.50000 187.0 264.5 400
Mean 72.75 41.43478 60.83333 63.18182 230.0 295.4 400
3rd Qu. 91.00 47.00000 86.00000 81.50000 363.5 318.0 400
Max. 182.00 144.00000 106.00000 176.00000 512.0 781.0 400

Trial Group Type

group_type Group_Count
Experimental 99
Active Comparator 26
NA 10
Other 4
Placebo Comparator 3
No Intervention 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 55
Parallel Assignment 34
NA 8
Crossover Assignment 1
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 93
Supportive Care 5
Diagnostic 1

Observational Studies

Studies by Country

Country Study_Count
United States 5
Chile 2
China 1
Italy 1
Korea, Republic of 1
Netherlands 1

Sites per Study

Site_count Study_Count
1 8
3 1
4 2

Enrollment Metrics

Measure Observational
Min 50.000
1st Qu 117.500
Median 144.000
Mean 4355.455
3rd Qu 473.000
Max 35000.000

Observation Model

observational_model Study_Count
Cohort 7
Case-Control 3
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 9
Retrospective 2

Registries

Studies by Country

Country Study_Count
Argentina|Australia|Austria|Belgium|Denmark|France|Germany|Italy|Poland|Russian Federation|Singapore|Spain|Switzerland 1
Canada 1
China 1
Korea, Republic of 1
United States 1

Sites per Study

Site_count Study_Count
1 2
16 1
55 1
75 1

Enrollment Metrics

Measure Registries
Min 100.0
1st Qu 1000.0
Median 2000.0
Mean 202619.8
3rd Qu 10000.0
Max 999999.0

Registry Model

observational_model Study_Count
Cohort 4
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 4
Cross-Sectional 1

Follow-up

target_duration Study_Count
5 Years 2
1 Year 1
2 Years 1
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT02920554 The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer https://ClinicalTrials.gov/show/NCT02920554 Recruiting Saint Vincent’s Hospital, Korea 2023-06-30
NCT03278106 TAS-102 in Treating Advanced Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT03278106 Active, not recruiting Mayo Clinic 2018-11-30
NCT03260712 Pembrolizumab in Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT03260712 Recruiting European Organisation for Research and Treatment of Cancer - EORTC 2022-11-01
NCT03257761 Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT03257761 Recruiting University of Southern California 2021-02-07
NCT03139487 A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03139487 Recruiting Asan Medical Center 2021-09-30
NCT03111732 Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) https://ClinicalTrials.gov/show/NCT03111732 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02867865 Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers https://ClinicalTrials.gov/show/NCT02867865 Recruiting Tata Memorial Hospital 2021-08-31
NCT02646514 Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study https://ClinicalTrials.gov/show/NCT02646514 Recruiting Yonsei University 2019-09-30
NCT02520141 Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02520141 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT02495896 Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT02495896 Active, not recruiting University of Southern California 2020-02-28
NCT02489422 Programs To Support You During Chemotherapy https://ClinicalTrials.gov/show/NCT02489422 Completed Wake Forest University Health Sciences 2020-01-31
NCT02430662 Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms https://ClinicalTrials.gov/show/NCT02430662 Recruiting Fuda Cancer Hospital, Guangzhou 2020-12-01
NCT02392637 Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers https://ClinicalTrials.gov/show/NCT02392637 Active, not recruiting M.D. Anderson Cancer Center 2020-04-30
NCT02351765 ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT02351765 Completed The Christie NHS Foundation Trust 2019-03-31
NCT02333188 Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02333188 Completed University of Chicago 2017-12-31
NCT02293954 Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer https://ClinicalTrials.gov/show/NCT02293954 Active, not recruiting City of Hope Medical Center 2020-06-30
NCT02170090 Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT02170090 Recruiting Universitätsklinikum Hamburg-Eppendorf 2021-04-30
NCT01313377 Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery https://ClinicalTrials.gov/show/NCT01313377 Completed UNICANCER 2016-06-30
NCT01308840 Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer https://ClinicalTrials.gov/show/NCT01308840 Completed University of Rochester 2013-01-31
NCT02042443 Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02042443 Completed National Cancer Institute (NCI) 2017-01-31
NCT01926236 Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT01926236 Completed The Christie NHS Foundation Trust 2018-01-05
NCT01643499 Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT01643499 Completed University of Chicago 2016-08-28
NCT01640522 Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms https://ClinicalTrials.gov/show/NCT01640522 Completed University of Pittsburgh 2013-12-31
NCT01425879 MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01425879 Completed National Cancer Institute (NCI) 2013-05-31
NCT01320241 Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture https://ClinicalTrials.gov/show/NCT01320241 Completed Southeast University, China 2012-03-31
NCT04426669 A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering https://ClinicalTrials.gov/show/NCT04426669 Recruiting Intima Bioscience, Inc. 2022-10-31
NCT04362449 Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration https://ClinicalTrials.gov/show/NCT04362449 Recruiting Imperial College Healthcare NHS Trust 2021-01-02
NCT04337333 Two-in-one Covered and Uncovered Metal Stent https://ClinicalTrials.gov/show/NCT04337333 Recruiting Ajou University School of Medicine 2020-12-31
NCT04333927 Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer https://ClinicalTrials.gov/show/NCT04333927 Active, not recruiting Sun Yat-sen University 2024-06-30
NCT04308174 Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04308174 Recruiting Asan Medical Center 2021-09-30
NCT04183712 Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA https://ClinicalTrials.gov/show/NCT04183712 Recruiting Shanghai Jiao Tong University School of Medicine 2021-05-31
NCT04072445 Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04072445 Recruiting Mayo Clinic 2021-05-15
NCT04068194 Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies https://ClinicalTrials.gov/show/NCT04068194 Recruiting National Cancer Institute (NCI) 2022-12-03
NCT03985072 Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor https://ClinicalTrials.gov/show/NCT03985072 Recruiting Andes Biotechnologies 2021-04-30
NCT03833661 M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) https://ClinicalTrials.gov/show/NCT03833661 Active, not recruiting EMD Serono 2020-11-09
NCT03772132 Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT03772132 Recruiting Shanghai Jiao Tong University School of Medicine 2020-12-31
NCT03768414 Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT03768414 Recruiting Southwest Oncology Group 2024-01-01
NCT03768375 Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT03768375 Recruiting Shanghai Jiao Tong University School of Medicine 2020-12-30
NCT03702491 Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT03702491 Recruiting Eastern Hepatobiliary Surgery Hospital 2020-08-10
NCT03673072 Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC https://ClinicalTrials.gov/show/NCT03673072 Recruiting Krankenhaus Nordwest 2024-11-30
NCT03473574 Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients https://ClinicalTrials.gov/show/NCT03473574 Recruiting AIO-Studien-gGmbH 2021-09-30
NCT01242605 ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT01242605 Completed University College, London 2013-03-31
NCT01118897 Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers https://ClinicalTrials.gov/show/NCT01118897 Completed Tata Memorial Hospital 2013-01-31
NCT01093222 Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01093222 Completed National Cancer Institute (NCI) 2012-09-30
NCT01053390 New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT01053390 Completed Shanghai Jiao Tong University School of Medicine 2013-12-31
NCT01016639 Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer https://ClinicalTrials.gov/show/NCT01016639 Completed Lund University Hospital 2007-07-31
NCT00987766 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer https://ClinicalTrials.gov/show/NCT00987766 Completed Vanderbilt-Ingram Cancer Center 2013-07-31
NCT00949949 Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy https://ClinicalTrials.gov/show/NCT00949949 Completed Mayo Clinic 2014-07-31
NCT00919061 Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy https://ClinicalTrials.gov/show/NCT00919061 Completed Memorial Sloan Kettering Cancer Center 2014-03-31
NCT04066491 Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) https://ClinicalTrials.gov/show/NCT04066491 Recruiting EMD Serono 2022-11-24
NCT01825603 ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01825603 Completed University of Nebraska 2017-06-30
NCT02836847 Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma https://ClinicalTrials.gov/show/NCT02836847 Recruiting Shanghai Jiao Tong University School of Medicine 2019-12-31
NCT02659852 A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction https://ClinicalTrials.gov/show/NCT02659852 Recruiting Yonsei University 2020-01-31
NCT00789958 S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct https://ClinicalTrials.gov/show/NCT00789958 Completed Southwest Oncology Group 2014-12-31
NCT00753675 Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00753675 Completed Sanofi 2012-09-30
NCT00660699 A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers https://ClinicalTrials.gov/show/NCT00660699 Completed Washington University School of Medicine 2010-09-30
NCT00660140 Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00660140 Completed Washington University School of Medicine 2007-01-31
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00654160 Completed Mayo Clinic 2010-11-30
NCT00544193 Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00544193 Completed City of Hope Medical Center 2012-08-31
NCT00513539 Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00513539 Completed University College, London 2009-12-31
NCT00486356 Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00486356 Completed University of Nebraska 2010-01-31
NCT00423254 Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. https://ClinicalTrials.gov/show/NCT00423254 Completed Mannkind Corporation 2009-09-30
NCT00409864 Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer https://ClinicalTrials.gov/show/NCT00409864 Completed All India Institute of Medical Sciences, New Delhi 2005-07-31
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00391183 Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. https://ClinicalTrials.gov/show/NCT00391183 Completed All India Institute of Medical Sciences, New Delhi 2012-12-31
NCT00363584 Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00363584 Completed National Cancer Institute (NCI) 2013-08-31
NCT00361231 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00361231 Completed Massachusetts General Hospital 2009-03-31
NCT00356889 Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors https://ClinicalTrials.gov/show/NCT00356889 Completed National Cancer Institute (NCI) 2008-10-31
NCT00350753 Avastin and Tarceva for Upper Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT00350753 Completed Rigshospitalet, Denmark 2009-06-30
NCT00338988 Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00338988 Completed M.D. Anderson Cancer Center 2009-05-31
NCT00304135 Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00304135 Completed Federation Francophone de Cancerologie Digestive 2012-12-31
NCT00280709 Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction https://ClinicalTrials.gov/show/NCT00280709 Completed University Hospital, Linkoeping 2008-10-31
NCT00266097 Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00266097 Completed UNC Lineberger Comprehensive Cancer Center 2009-03-31
NCT00262769 Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors https://ClinicalTrials.gov/show/NCT00262769 Completed University College, London 2008-08-31
NCT00238212 S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00238212 Completed National Cancer Institute (NCI) 2007-01-31
NCT00142480 Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00142480 Completed Massachusetts General Hospital 2007-07-31
NCT00123825 Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00123825 Completed Dana-Farber Cancer Institute 2007-10-31
NCT00107536 Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00107536 Completed National Cancer Institute (NCI) 2009-05-31
NCT00101036 Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00101036 Completed National Cancer Institute (NCI) 2009-01-31
NCT00003557 Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00003557 Completed University of Chicago 2000-06-30
NCT00084942 Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder https://ClinicalTrials.gov/show/NCT00084942 Completed Roswell Park Cancer Institute 2004-05-31
NCT00004604 Biological Therapy in Treating Patients With Metastatic Cancer https://ClinicalTrials.gov/show/NCT00004604 Completed Duke University 2001-06-30
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00003427 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00005938 DX-8951f in Treating Patients With Biliary Cancer https://ClinicalTrials.gov/show/NCT00005938 Completed Daiichi Sankyo, Inc. 2005-04-30
NCT00003411 Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer https://ClinicalTrials.gov/show/NCT00003411 Completed University of Pittsburgh 2002-06-30
NCT00003046 Interleukin-12 in Treating Patients With Cancer in the Abdomen https://ClinicalTrials.gov/show/NCT00003046 Completed M.D. Anderson Cancer Center 2001-10-31
NCT00003923 Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas https://ClinicalTrials.gov/show/NCT00003923 Completed Memorial Sloan Kettering Cancer Center 2002-02-28
NCT00075504 Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00075504 Completed National Cancer Institute (NCI) 2009-01-31
NCT00009893 Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00009893 Completed Alliance for Clinical Trials in Oncology 2005-01-31
NCT00073905 Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00073905 Completed Swiss Group for Clinical Cancer Research 2006-06-30
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00033462 Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00033462 Completed National Cancer Institute (NCI) 2006-11-30
NCT00059865 Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00059865 Completed Alliance for Clinical Trials in Oncology 2007-02-28
NCT00033540 S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00033540 Completed Southwest Oncology Group 2008-04-30
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00028496 Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00028496 Completed National Cancer Institute (NCI) 2005-11-30
NCT00027534 Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00027534 Completed Duke University 2007-10-31
NCT00019513 Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00019513 Completed National Institutes of Health Clinical Center (CC) NA
NCT00003276 Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer https://ClinicalTrials.gov/show/NCT00003276 Completed Alliance for Clinical Trials in Oncology 2001-03-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03133286 Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) https://ClinicalTrials.gov/show/NCT03133286 Recruiting DxTerity Diagnostics 2019-09-06
NCT02692911 Chile Biliary Longitudinal Study https://ClinicalTrials.gov/show/NCT02692911 Recruiting National Institutes of Health Clinical Center (CC) 2023-12-31
NCT02326948 Alcohol Consumption and Gallbladder Cancer https://ClinicalTrials.gov/show/NCT02326948 Completed Cheju Halla General Hospital 2014-11-30
NCT01520259 Initial Study of Gallbladder Cancer in Chile https://ClinicalTrials.gov/show/NCT01520259 Completed National Institutes of Health Clinical Center (CC) NA
NCT03668418 Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos https://ClinicalTrials.gov/show/NCT03668418 Recruiting University of Pisa 2021-05-31
NCT03581435 A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients https://ClinicalTrials.gov/show/NCT03581435 Recruiting Shanghai Jiao Tong University School of Medicine 2018-12-30
NCT01135849 B-Receptor Signaling in Cardiomyopathy https://ClinicalTrials.gov/show/NCT01135849 Completed Stanford University 2010-10-31
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00836992 Completed Mayo Clinic 2011-09-15
NCT03510923 Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy https://ClinicalTrials.gov/show/NCT03510923 Active, not recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2020-02-01
NCT00579865 Quality Of Life in Patients With Malignant Biliary Obstruction https://ClinicalTrials.gov/show/NCT00579865 Completed Memorial Sloan Kettering Cancer Center 2010-01-31
NCT00489515 Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder https://ClinicalTrials.gov/show/NCT00489515 Completed Wake Forest University Health Sciences 2009-06-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03210298 International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) https://ClinicalTrials.gov/show/NCT03210298 Recruiting University of Magdeburg 2022-09-30
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31
NCT04140552 Chinese Research Group of Gallbladder Cancer https://ClinicalTrials.gov/show/NCT04140552 Recruiting Shanghai Jiao Tong University School of Medicine 2020-12-31
NCT04104230 Quebec Pancreas Cancer Study https://ClinicalTrials.gov/show/NCT04104230 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2025-01-31
NCT03637569 The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer https://ClinicalTrials.gov/show/NCT03637569 Recruiting Samsung Medical Center 2020-04-30